Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer.

Stover EH, Baco MB, Cohen O, Li YY, Christie EL, Bagul M, Goodale A, Lee Y, Pantel S, Rees MG, Wei G, Presser AG, Gelbard MK, Zhang W, Zervantonakis IK, Bhola PD, Ryan J, Guerriero JL, Montero J, Liang FJ, Cherniack AD, Piccioni F, Matulonis UA, Bowtell DDL, Sarosiek KA, Letai A, Garraway LA, Johannessen CM, Meyerson M.

Mol Cancer Res. 2019 Aug 28. doi: 10.1158/1541-7786.MCR-18-1243. [Epub ahead of print]

PMID:
31462500
2.

Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.

Mills SA, Gelbard MK.

World J Urol. 2019 Jun 5. doi: 10.1007/s00345-019-02818-3. [Epub ahead of print]

PMID:
31168744
3.

Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach.

Gelbard MK, Chagan L, Tursi JP.

J Sex Med. 2015 Jun;12(6):1481-9. doi: 10.1111/jsm.12904. Epub 2015 May 5. Review.

PMID:
25940867
4.

Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.

Levine LA, Cuzin B, Mark S, Gelbard MK, Jones NA, Liu G, Kaufman GJ, Tursi JP, Ralph DJ.

J Sex Med. 2015 Jan;12(1):248-58. doi: 10.1111/jsm.12731. Epub 2014 Nov 12.

PMID:
25388099
5.

Fractured penis: diagnosis and management--a comment.

Gelbard MK.

J Sex Med. 2010 Jun;7(6):2288. doi: 10.1111/j.1743-6109.2010.01813.x. Epub 2010 Apr 26. No abstract available.

PMID:
20456633
6.

The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman.

Glina S, Gelbard MK, Akkus E, Jordan GH, Levine LA.

J Sex Med. 2007 Sep;4(5):1209-13. No abstract available.

PMID:
17727345
7.
8.

Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study.

Gelbard MK, James K, Riach P, Dorey F.

J Urol. 1993 Jan;149(1):56-8.

PMID:
8417217
9.
10.

The natural history of Peyronie's disease.

Gelbard MK, Dorey F, James K.

J Urol. 1990 Dec;144(6):1376-9.

PMID:
2231932
11.

Controlled vacuum chamber for standardized photographic documentation of penile erectile deformity.

Gelbard MK.

Urology. 1990 Oct;36(4):367-9. No abstract available.

PMID:
2219623
12.

A technique for immediate realignment and catheterization of the disrupted prostatomembranous urethra.

Gelbard MK, Heyman AM, Weintraub P.

J Urol. 1989 Jul;142(1):52-5.

PMID:
2733109
13.

Penile retractor.

Gelbard MK.

J Urol. 1989 Jan;141(1):91. No abstract available.

PMID:
2908962
14.

Dystrophic penile calcification in Peyronie's disease.

Gelbard MK.

J Urol. 1988 Apr;139(4):738-40.

PMID:
3352034
15.

Disposable Frazier neurosurgery suction tip as intrarenal stone irrigator.

Gelbard MK.

Urology. 1987 May:44. No abstract available.

PMID:
3590459
16.

Humoral immune responses in Peyronie's disease patients receiving clostridial collagenase therapy.

Hamilton RG, Mintz GR, Gelbard MK.

J Urol. 1986 Mar;135(3):641-7.

PMID:
2868133
17.

The use of collagenase in the treatment of Peyronie's disease.

Gelbard MK, Lindner A, Kaufman JJ.

J Urol. 1985 Aug;134(2):280-3.

PMID:
2991611
18.

Removal of small cactus spines from the skin.

Gelbard MK.

JAMA. 1984 Dec 28;252(24):3368. No abstract available.

PMID:
6502905
19.

Familial pheochromocytomas.

Tank ES, Gelbard MK, Blank B.

J Urol. 1982 Nov;128(5):1013-6. No abstract available.

PMID:
6129330
20.

Disposable Frazier neurosurgery suction tip as intrarenal stone irrigator.

Gelbard MK.

Urology. 1982 Apr;19(4):430. No abstract available.

PMID:
7072038
21.

Collagenase for Peyronie's disease experimental studies.

Gelbard MK, Walsh R, Kaufman JJ.

Urol Res. 1982;10(3):135-40.

PMID:
6291216

Supplemental Content

Loading ...
Support Center